• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Code Mucor: Guidelines for the Diagnosis, Staging and Management of Rhino-Orbito-Cerebral Mucormycosis in the Setting of COVID-19.

作者信息

Honavar Santosh G

机构信息

Editor, Indian Journal of Ophthalmology, Centre for Sight, Road No 2, Banjara Hills, Hyderabad - 500 034, Telangana, India.

出版信息

Indian J Ophthalmol. 2021 Jun;69(6):1361-1365. doi: 10.4103/ijo.IJO_1165_21.

DOI:10.4103/ijo.IJO_1165_21
PMID:34011699
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8302268/
Abstract
摘要

相似文献

1
Code Mucor: Guidelines for the Diagnosis, Staging and Management of Rhino-Orbito-Cerebral Mucormycosis in the Setting of COVID-19.毛霉代码：2019冠状病毒病背景下鼻眶脑型毛霉病的诊断、分期和管理指南
Indian J Ophthalmol. 2021 Jun;69(6):1361-1365. doi: 10.4103/ijo.IJO_1165_21.
2
Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.是否意味着毛霉菌病的终结？COVID 相关的鼻-眶-脑毛霉菌病的全面管理：保留可挽救的。
Eur Arch Otorhinolaryngol. 2023 Feb;280(2):819-827. doi: 10.1007/s00405-022-07620-3. Epub 2022 Sep 2.
3
Post-COVID-19 rhino-orbito-cerebral mucormycosis: a new addition to challenges in pandemic control.新冠后 rhino-orbito-cerebral mucormycosis：大流行控制挑战的新挑战。
Eur Arch Otorhinolaryngol. 2022 May;279(5):2417-2422. doi: 10.1007/s00405-021-07010-1. Epub 2021 Jul 26.
4
COVID-associated rhinocerebral mucormycosis: a retrospective analysis of presentation and outcomes.COVID 相关的鼻-脑毛霉菌病：临床表现和结局的回顾性分析。
Eur Arch Otorhinolaryngol. 2023 Feb;280(2):713-721. doi: 10.1007/s00405-022-07544-y. Epub 2022 Jul 18.
5
Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.印度 2826 例 COVID-19 相关的鼻-眶-脑毛霉菌病的流行病学、临床特征、治疗和结局 - 合作 OPAI-IJO 新冠病毒相关毛霉菌病研究（COSMIC），报告 1。
Indian J Ophthalmol. 2021 Jul;69(7):1670-1692. doi: 10.4103/ijo.IJO_1565_21.
6
Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center.鼻眶脑型毛霉菌病：我们在一家三级护理中心的临床特征和治疗方面的经验。
Rom J Ophthalmol. 2021 Oct-Dec;65(4):339-353. doi: 10.22336/rjo.2021.69.
7
The ROC Staging System for COVID-related Rhino-Orbital-Cerebral Mucormycosis.新型冠状病毒相关鼻眶脑毛霉菌病的ROC分期系统
Semin Ophthalmol. 2022 Apr 3;37(3):279-283. doi: 10.1080/08820538.2021.1946094. Epub 2021 Jul 14.
8
Rhino-orbito-cerebral mucormycosis and its resurgence during COVID-19 pandemic: A review.COVID-19 大流行期间的鼻-眶-脑毛霉病及其再现：综述。
Indian J Ophthalmol. 2023 Jan;71(1):39-56. doi: 10.4103/ijo.IJO_1219_22.
9
Mucormycosis in head and neck area - the emerging health problem in COVID-19 pandemic. The perspective of a dental practitioner.头颈部毛霉菌病——COVID-19 大流行中的新兴健康问题。牙医的观点。
Folia Med Cracov. 2021;61(2):117-127. doi: 10.24425/fmc.2021.137228.
10
COVID-19 and orbital mucormycosis.新型冠状病毒肺炎与眼眶毛霉菌病
Indian J Ophthalmol. 2021 Apr;69(4):1002-1004. doi: 10.4103/ijo.IJO_3763_20.

引用本文的文献

1
Craniofacial Involvement of Mucormycosis: A Single-Center Experience of 57 Cases From Shiraz, Iran.毛霉菌病的颅面部累及：来自伊朗设拉子的57例单中心经验
Can J Infect Dis Med Microbiol. 2025 Jul 30;2025:4780569. doi: 10.1155/cjid/4780569. eCollection 2025.
2
Analysis of the clinical parameters and management aspects of rhino-maxillary mucormycosis, Part I: challenges in diagnosis.鼻上颌毛霉菌病的临床参数及管理方面分析，第一部分：诊断挑战
BMC Oral Health. 2025 Jul 31;25(1):1286. doi: 10.1186/s12903-025-05842-5.
3
One-Year Patient Survival After COVID-19-Associated Rhino-Orbital-Cerebral Mucormycosis: A Multicenter Study.

本文引用的文献

1
Orbital infarction syndrome secondary to rhino-orbital mucormycosis in a case of COVID-19: Clinico-radiological features.COVID-19 相关的鼻眶脑毛霉菌病继发眼眶梗死综合征：临床-放射学特征。
Indian J Ophthalmol. 2021 Jun;69(6):1627-1630. doi: 10.4103/ijo.IJO_1053_21.
2
Rise of the phoenix: Mucormycosis in COVID-19 times.凤凰涅槃：新冠时期的毛霉菌病。
Indian J Ophthalmol. 2021 Jun;69(6):1563-1568. doi: 10.4103/ijo.IJO_310_21.
3
COVID-19 and orbital mucormycosis.新型冠状病毒肺炎与眼眶毛霉菌病
新型冠状病毒肺炎相关鼻眶脑型毛霉病后的患者一年生存率：一项多中心研究
Mycopathologia. 2025 Jul 6;190(4):63. doi: 10.1007/s11046-025-00966-2.
4
Treatment and Survival Outcomes in Rhino-Orbital Mucormycosis with and without Orbital Exenteration: A Retrospective Case Series and Literature Review.有或无眼眶内容剜除术的鼻眶毛霉菌病的治疗及生存结果：一项回顾性病例系列研究及文献综述
Int Med Case Rep J. 2025 Jun 24;18:747-762. doi: 10.2147/IMCRJ.S530233. eCollection 2025.
5
Survival and prognostic factors in rhino-orbito-cerebral mucormycosis: A 3-year cohort study.鼻眶脑型毛霉菌病的生存及预后因素：一项为期3年的队列研究。
Sci Rep. 2025 May 8;15(1):16088. doi: 10.1038/s41598-025-98926-9.
6
Comparative Evaluation of Effectiveness of Standard of Care Alone and in Combination With Homoeopathic Treatment in COVID-19-Related Rhino-Orbito-Cerebral Mucormycosis (ROCM): Protocol for a Single Blind, Randomized Controlled Trial.标准治疗单独使用及联合顺势疗法治疗新型冠状病毒肺炎相关鼻眶脑毛霉菌病（ROCM）的有效性比较评估：一项单盲随机对照试验方案
JMIR Res Protoc. 2025 Mar 19;14:e57905. doi: 10.2196/57905.
7
Pterygopalatine Fossa- A Keystone Area in Disease Progression and Management in Rhino-Oculo-Cerebral Mucormycosis.翼腭窝——鼻-眼-脑型毛霉菌病疾病进展与管理中的关键区域
Indian J Otolaryngol Head Neck Surg. 2025 Jan;77(1):82-88. doi: 10.1007/s12070-024-05114-8. Epub 2024 Oct 19.
8
Antifungal Policy and Practice Across Five Countries: A Qualitative Review.五个国家的抗真菌政策与实践：一项定性综述
J Fungi (Basel). 2025 Feb 19;11(2):162. doi: 10.3390/jof11020162.
9
Estimation of the pattern of ocular manifestations, risk factors, and imaging of rhino-orbital-cerebral mucormycosis in COVID-19 patients.新型冠状病毒肺炎患者鼻眶脑型毛霉菌病眼部表现模式、危险因素及影像学评估
J Family Med Prim Care. 2025 Jan;14(1):259-267. doi: 10.4103/jfmpc.jfmpc_1161_24. Epub 2025 Jan 13.
10
Orbital compartment syndrome in orbital mucormycosis: spot the threat through radiologist's eye.眼眶毛霉菌病中的眼眶间隔综合征：通过放射科医生的视角发现威胁
Emerg Radiol. 2025 Apr;32(2):217-224. doi: 10.1007/s10140-025-02318-5. Epub 2025 Feb 13.
Indian J Ophthalmol. 2021 Apr;69(4):1002-1004. doi: 10.4103/ijo.IJO_3763_20.
4
COVID-19 and Eye: A Review of Ophthalmic Manifestations of COVID-19.COVID-19 与眼睛：COVID-19 眼部表现的综述。
Indian J Ophthalmol. 2021 Mar;69(3):488-509. doi: 10.4103/ijo.IJO_297_21.
5
Mucor in a Viral Land: A Tale of Two Pathogens.霉菌在病毒之地：两种病原体的故事。
Indian J Ophthalmol. 2021 Feb;69(2):244-252. doi: 10.4103/ijo.IJO_3774_20.
6
Epidemiology and Diagnosis of Mucormycosis: An Update.毛霉病的流行病学与诊断：最新进展
J Fungi (Basel). 2020 Nov 2;6(4):265. doi: 10.3390/jof6040265.
7
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.全球毛霉病诊断和管理指南：欧洲医学真菌学会联合会与真菌感染研究组教育和研究联盟合作开展的一项倡议。
Lancet Infect Dis. 2019 Dec;19(12):e405-e421. doi: 10.1016/S1473-3099(19)30312-3. Epub 2019 Nov 5.
8
Therapy of Mucormycosis.毛霉菌病的治疗
J Fungi (Basel). 2018 Jul 31;4(3):90. doi: 10.3390/jof4030090.
9
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.欧洲癌症研究与治疗组织/侵袭性真菌感染合作组和美国国立过敏与传染病研究所真菌病研究组（EORTC/MSG）共识组对侵袭性真菌病的修订定义。
Clin Infect Dis. 2008 Jun 15;46(12):1813-21. doi: 10.1086/588660.